Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19
José Lucas Martins Rocha, Waldir César Ferreira de Oliveira, Nádia Cássia Noronha, et al.
Stem Cell Reviews and Reports (2020) Vol. 17, Iss. 1, pp. 71-93
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Morteza Zarrabi, Mohammad Amin Shahrbaf, Masoumeh Nouri, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43
Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment
Arefeh Basiri, Fatemeh Mansouri, Arezo Azari, et al.
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 1, pp. 193-213
Open Access | Times Cited: 45
Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Reactive Oxygen Species in the Adverse Outcome Pathway Framework: Toward Creation of Harmonized Consensus Key Events
Shihori Tanabe, Jason M. O’Brien, Knut Erik Tollefsen, et al.
Frontiers in Toxicology (2022) Vol. 4
Open Access | Times Cited: 37
Translating extracellular vesicle packaging into therapeutic applications
Dilara C. Ozkocak, Thanh Kha Phan, Ivan K. H. Poon
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19
Angliana Chouw, Tiana Milanda, Cynthia Retna Sartika, et al.
Regenerative Engineering and Translational Medicine (2021) Vol. 8, Iss. 1, pp. 43-54
Open Access | Times Cited: 27
Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects: Update from 2015 review
Leah A. Marquez‐Curtis, Janet A.W. Elliott
Cryobiology (2024) Vol. 115, pp. 104856-104856
Open Access | Times Cited: 4
INF-γ/TGF-β1-primed umbilical cord mesenchymal stem cells boost the T-lymphocytes activity: Modulation of CD25 expression and IL-6 secretion
Abdulrahman H. Almaeen, Heba M Saad-Eldien, Hala Gabr
International Journal of Immunopathology and Pharmacology (2025) Vol. 39
Open Access
Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era
Birbal Singh, Gorakh Mal, Vinod Verma, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Treatment of Viral Diseases
Carl Randall Harrell, Biljana Popovska Jovičić, Valentin Djonov, et al.
Pathogens (2021) Vol. 10, Iss. 4, pp. 409-409
Open Access | Times Cited: 13
Mechanism of Mesenchymal Stem Cells as a Multitarget Disease- Modifying Therapy for Parkinson's Disease
Aziz Unnisa, Kamal Dua, Mohammad Amjad Kamal
Current Neuropharmacology (2022) Vol. 21, Iss. 4, pp. 988-1000
Open Access | Times Cited: 9
Stem cell therapy for COVID-19 pneumonia
Maziar Malekzadeh Kebria, Peiman Brouki Milan, Noshad Peyravian, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 8
hMSCs treatment attenuates murine herpesvirus-68 (MHV-68) pneumonia through altering innate immune response via ROS/NLRP3 signaling pathway
Aiping Qin, Xiaojuan Wang, Jijun Fu, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 4
Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19
Xiaoyun Cheng, Mao Jiang, Lingzhi Long, et al.
Frontiers in Bioscience-Landmark (2021) Vol. 26, Iss. 10, pp. 948-948
Open Access | Times Cited: 10
Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2
Vishal Khandelwal, Tarubala Sharma, Saurabh Gupta, et al.
Molecular Biology Reports (2022) Vol. 50, Iss. 3, pp. 2663-2683
Open Access | Times Cited: 7
Mesenchymal Stem Cells: Potential Role against Bacterial Infection
Basem Battah
Journal of Biosciences and Medicines (2022) Vol. 10, Iss. 03, pp. 97-113
Open Access | Times Cited: 6
Stromal cell therapy in cats with feline chronic gingivostomatitis: current perspectives and future direction
Iris L Rivas, Maria Soltero‐Rivera, Natalia Vapniarsky, et al.
Journal of Feline Medicine and Surgery (2023) Vol. 25, Iss. 8
Open Access | Times Cited: 2
Convalescent plasma therapy - a silver lining for COVID-19 management?
Sumit Saha, Sachin Kadam
Hematology Transfusion and Cell Therapy (2021) Vol. 43, Iss. 2, pp. 201-211
Open Access | Times Cited: 5
Stem Cells as a Model of Study of SARS-CoV-2 and COVID-19: A Systematic Review of the Literature
María Verónica Cuevas-González, Álvaro García Pérez, Álvaro Edgar González-Aragón Pineda, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-7
Open Access | Times Cited: 5
Microencapsulated wharton jelly-derived adult mesenchymal stem cells as a potential new therapeutic tool for patients with covid-19 disease: An in vitro study
Pia Montanucci, Teresa Pescara, Alessia Greco, et al.
Journal of Stem Cells (2021) Vol. 10, Iss. 3, pp. 36-52
Closed Access | Times Cited: 4
Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?
Sudha Warrier, Sumati Sundaram, Lavanya Varier, et al.
Placenta (2021) Vol. 117, pp. 161-168
Open Access | Times Cited: 4
Stem Cell Therapy for SARS-CoV-2 and Influenza Virus Infections
Neelabh Datta
BIO Integration (2024) Vol. 5, Iss. 1
Open Access
Targeting Cytokines: Evaluating the Potential of Mesenchymal Stem Cell Derived Extracellular Vesicles in the Management of COVID-19
Iago Carvalho Schultz, Ana Cláudia dos Santos Pereira Andrade, Isabelle Dubuc, et al.
Stem Cell Reviews and Reports (2024)
Closed Access
Respiratory viruses induce the expression of type I and III IFNs in MSCs through RLR/IRF3 signaling pathways
Jhao‐Yin Lin, Hsing‐I Huang
Microbes and Infection (2023) Vol. 25, Iss. 7, pp. 105171-105171
Open Access | Times Cited: 1
Tendon-Derived Mesenchymal Stem Cells (TDSCs) as an In Vitro Model for Virological Studies in Wild Birds
José Rivas, Axel Dubois, Aude Blanquer, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1455-1455
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top